Cargando…
A case of hyperpigmentation induced by hydroxychloroquine and quinacrine in a patient with systemic lupus erythematosus and review of the literature
Hydroxychloroquine (HQ) and quinacrine are widely used antimalarials for systemic lupus erythematosus (SLE) and other autoimmune diseases. We report a case of antimalarial-induced hyperpigmentation in a 57-year old African-American woman. The patient had a long-standing history of SLE that was treat...
Autores principales: | Kwak, Daniel, Grimes, Pearl E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522856/ https://www.ncbi.nlm.nih.gov/pubmed/33015284 http://dx.doi.org/10.1016/j.ijwd.2020.06.009 |
Ejemplares similares
-
Hydroxychloroquine-induced hyperpigmentation in a 14-year-old female with systemic lupus erythematosus
por: Leung, Alexander KC, et al.
Publicado: (2020) -
Candidate drug replacements for quinacrine in cutaneous lupus erythematosus
por: Yan, Daisy, et al.
Publicado: (2020) -
Hyperpigmentation Induced by Hydroxychloroquine
por: Hamri, Laila
Publicado: (2023) -
Diffuse Facial Hyperpigmentation as a Presenting Sign of Lupus Erythematosus: Three Cases and Review of the Literature
por: Azrielant, Shir, et al.
Publicado: (2021) -
Hydroxychloroquine-induced retinal toxicity in systemic lupus erythematosus
por: Piggott, Kisha D, et al.
Publicado: (2018)